Prognostic implications of plasma volume status estimates in heart failure with preserved ejection fraction: insights from TOPCAT

Calculated Estimates of Plasma Volume in Patients With Chronic Heart Failure—Comparison With Measured Volumes

(2018) Marat Fudim et al.   JOURNAL OF CARDIAC FAILURE

Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction

(2017) Inder S. Anand et al.   JACC-Heart Failure

Fluid Volume Overload and Congestion in Heart Failure

(2016) Wayne L. Miller   Circulation-Heart Failure

Change in plasma volume and prognosis in acute decompensated heart failure: an observational cohort study

(2016) Sarah R Hudson et al.   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE

Volume Overload Profiles in Patients With Preserved and Reduced Ejection Fraction Chronic Heart Failure

(2016) Wayne L. Miller et al.   JACC-Heart Failure

Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials

(2015) Jacob P. Kelly et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prognostic Value of Estimated Plasma Volume in Heart Failure

(2015) Kévin Duarte et al.   JACC-Heart Failure

Calculated plasma volume status and prognosis in chronic heart failure

(2014) Hua Zen Ling et al.   EUROPEAN JOURNAL OF HEART FAILURE

Spironolactone for Heart Failure with Preserved Ejection Fraction

(2014) Bertram Pitt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction

(2011) Akshay S. Desai et al.   AMERICAN HEART JOURNAL

Impact of diuretic treatment and sodium intake on plasma volume in patients with compensated systolic heart failure

(2010) Peter K. Bonfils et al.   EUROPEAN JOURNAL OF HEART FAILURE